Dhampur Bio Organics Intrinsic Value
Dhampur Bio Organics (DBOL) median intrinsic value is ₹239.32 from 4 valuation models (range ₹48–₹299), vs current price ₹119.66 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit DBOL share price.
DBOL Valuation Methods Summary — DCF, Graham Number & P/E
Dhampur Bio Organics intrinsic value across 4 models vs current price ₹119.66 — upside/downside and value range per method. Browse DBOL balance sheet details for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹299.15 | ₹269.24 - ₹329.06 | +150.0% | Book Value/Share: ₹153.33, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹239.32 | ₹215.39 - ₹263.25 | +100.0% | Revenue/Share: ₹346.06, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹47.86 | ₹43.07 - ₹52.65 | -60.0% | EBITDA: ₹20.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹182.86 | ₹146.29 - ₹219.43 | +52.8% | CF Growth: 5.0%, Discount: 15% |
DBOL Intrinsic Value vs Market Price — All Valuation Models
Dhampur Bio Organics fair value range ₹48–₹299 vs current market price ₹119.66 across 4 valuation models. Compare with DBOL intrinsic value calculation to assess whether the stock is under or overvalued.
DBOL Intrinsic Value Analysis — Undervalued or Overvalued?
Dhampur Bio Organics median intrinsic value ₹239.32, current price ₹119.66 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of DBOL?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Dhampur Bio Organics (DBOL) is ₹239.32 (median value). With the current market price of ₹119.66, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹47.86 to ₹299.15, indicating ₹47.86 - ₹299.15.
Is DBOL undervalued or overvalued?
Based on our multi-method analysis, Dhampur Bio Organics (DBOL) appears to be trading below calculated value by approximately 100.0%.
DBOL Financial Health — Key Ratios vs Industry Benchmarks
Dhampur Bio Organics financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.04 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -6.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.95x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
DBOL Cash Flow Quality — Operating & Free Cash Flow
Dhampur Bio Organics operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹130 Cr | ₹57 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹-101 Cr | ₹-184 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹368 Cr | ₹264 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-247 Cr | ₹-309 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |